Related Experiment Video
Updated: Aug 7, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists
Bing Li1, Stephen J Russell, Deanne M Compaan
1Department of Protein Engineering, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Abstract:
The cell-extrinsic apoptotic pathway triggers programmed cell death in response to certain ligands that bind to cell-surface death receptors. Apoptosis is essential for normal development and homeostasis in metazoans, and furthermore, selective activation of the cell-extrinsic pathway in tumor cells holds considerable promise for cancer therapy. We used phage display to identify peptides and synthetic antibodies that specifically bind to the human proapoptotic death receptor DR5. Despite great differences in overall size and structure, the DR5-binding peptides and antibodies shared a tripeptide motif, which was conserved within a disulfide-constrained loop of the peptides and the third complementarity determining region of the antibody heavy chains. The X-ray crystal structure of an antibody in complex with DR5 revealed that the tripeptide motif is buried at the core of the interface, confirming its central role in antigen recognition. We found that certain peptides and antibodies exhibited potent proapoptotic activity against DR5-expressing SK-MES-1 lung carcinoma cells. These phage-derived ligands may be useful for elucidating DR5 activation at the molecular level and for creating synthetic agonists of proapoptotic death receptors.
Insights
Researchers identified a key tripeptide motif in DR5-binding peptides and antibodies. This motif is crucial for recognizing the death receptor DR5 and shows potential for cancer therapy by inducing apoptosis.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- The cell-extrinsic apoptotic pathway is vital for development and homeostasis.
- Targeting this pathway in cancer cells offers therapeutic potential.
- DR5 is a key cell-surface death receptor involved in apoptosis.
Purpose of the Study:
- To identify novel ligands that bind to the human death receptor DR5.
- To characterize the molecular basis of DR5-ligand interactions.
- To explore the therapeutic potential of DR5-targeting agents.
Main Methods:
- Phage display technology was employed to discover DR5-binding peptides and antibodies.
- X-ray crystallography was used to determine the structural basis of DR5-ligand binding.
- Functional assays were performed to assess the proapoptotic activity of identified ligands.
Main Results:
- A conserved tripeptide motif was identified in both DR5-binding peptides and antibodies.
- This motif was found to be critical for DR5 recognition, located at the interface core.
- Selected peptides and antibodies demonstrated potent proapoptotic activity in DR5-expressing lung cancer cells.
Conclusions:
- The identified tripeptide motif is central to DR5 antigen recognition.
- Phage-derived ligands targeting DR5 hold promise for cancer therapy.
- These ligands can aid in understanding DR5 activation and developing synthetic agonists.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

